LAP3 and inflammatory bowel disease: In this regard, polyethylene glycol (PEG)–modified AM (PEG-AM) is effective in animal models of IBD without compromising the original efficacy of AM, avoiding degradation by peptidases, and extending blood duration by reducing renal clearance.92